Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Payables (2017 - 2025)

Historic Payables for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Regenerative Medical Technology's Payables fell 9192.99% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 9192.99%. This contributed to the annual value of $18.3 million for FY2024, which is 55216.66% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Payables stood at $1.5 million for Q3 2025, which was down 9192.99% from $17.9 million recorded in Q2 2025.
  • Regenerative Medical Technology's Payables' 5-year high stood at $20.2 million during Q2 2024, with a 5-year trough of $1.5 million in Q3 2025.
  • Its 5-year average for Payables is $14.0 million, with a median of $15.3 million in 2022.
  • Per our database at Business Quant, Regenerative Medical Technology's Payables surged by 55216.66% in 2024 and then plummeted by 9192.99% in 2025.
  • Over the past 5 years, Regenerative Medical Technology's Payables (Quarter) stood at $13.5 million in 2021, then grew by 13.29% to $15.3 million in 2022, then tumbled by 81.69% to $2.8 million in 2023, then skyrocketed by 552.17% to $18.3 million in 2024, then tumbled by 91.86% to $1.5 million in 2025.
  • Its Payables stands at $1.5 million for Q3 2025, versus $17.9 million for Q2 2025 and $18.3 million for Q1 2025.